Air Products and Chemicals Down Over 11%, on Pace for Largest Percent Decrease Since March 2020 — Data Talk
Air Products and Chemicals, Inc. (APD) is currently at $258.26, down $33.05 or 11.34%
--Would be lowest close since Nov. 2, 2022, when it closed at $245.17
--On pace for largest percent decrease since March 16, 2020, when it fell 12.6%
--Currently down two consecutive days; down 11.92% over this period
--Worst two day stretch since the two days ending Nov. 12, 2020, when it fell 14.41%
--Down 8.56% month-to-date
--Down 16.22% year-to-date; on pace for worst year since 2008, when it fell 49.03%
--Down 20.6% from its all-time closing high of $325.25 on Dec. 13, 2022
--Down 8.74% from 52 weeks ago (Nov. 8, 2022), when it closed at $283.00
--Down 20.6% from its 52-week closing high of $325.25 on Dec. 13, 2022
--Would be a new 52-week closing low
--Traded as low as $258.00; lowest intraday level since Nov. 3, 2022, when it hit $247.13
--Down 11.43% at today's intraday low; largest intraday percent decrease since March 16, 2020, when it fell as much as 18.87%
--Worst performer in the S&P 500 today
All data as of 10:14:06 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 07, 2023 10:32 ET (15:32 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom